Identifying and Validating Predictive Biomarkers in Advanced Oesophagael Adenocarcinoma - A Springboard to REAListic Medicine (BE-REAL)

Medicine & Life Sciences

1. Adenocarcinoma 100%
2. Survival 85%
3. Precision Medicine 83%
4. Esophageal Neoplasms 82%
5. Neoplasms 82%
6. Scotland 75%
7. Frailty 73%
8. Drug Therapy 58%
9. Pandemics 48%
10. Erlotinib Hydrochloride 46%
11. Geriatrics 44%
12. Esophageal Squamous Cell Carcinoma 43%
13. Delirium 41%
14. Cardiotoxicity 41%
15. Therapeutics 36%
16. Psychological Distress 36%
17. Social Support 35%
18. Estrogen Receptors 33%
19. Stomach Neoplasms 31%
20. Population 29%
21. Clinical Trials 28%
22. Observational Studies 28%
23. Elderly 24%
24. Palliative Care 23%
25. Chemoradiotherapy 19%
26. Incidence 16%
27. Morbidity 16%
28. Patient Selection 15%
29. Quality of Life 15%
30. Survival Rate 13%
31. Regression Analysis 11%
32. Cause of Death 9%
33. Comorbidity 9%
34. Cardiovascular Diseases 8%
35. Informed Consent 8%
36. Endosonography 7%
37. Stents 7%
38. Research Ethics 7%
39. Colorectal Neoplasms 7%
40. Proteins 6%
41. Gastroscopy 6%
42. Prospective Studies 6%
43. Neoadjuvant Therapy 5%
44. Breast Neoplasms 5%
45. National Health Programs 5%
46. Perioperative Period 5%
47. Electronic Health Records 5%
48. Ethics 5%
49. Immunohistochemistry 5%